Soluventis Nanotherapeutics Overview
- Year Founded
-
2009
- Status
-
Private
- Employees
-
8
- Latest Deal Type
-
2ndary - Private
- Investors
-
1
Soluventis Nanotherapeutics General Information
Description
Developer of oligonucleotide therapeutics designed to transport therapeutic nucleic acids and peptides. The company's therapeutics help in transporting the active substances from the blood and the immune system and reaching reliable target organs, including poorly vascularized tumor tissue, enabling clinicians to reduce tumor bulges in a shorter period.
Contact Information
Website
www.soluventis.deCorporate Office
- 136 Universitätsstr.
- 44799 Bochum
- Germany
Corporate Office
- 136 Universitätsstr.
- 44799 Bochum
- Germany
Soluventis Nanotherapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Secondary Transaction - Private | 16-Jan-2026 | Completed | Generating Revenue | |||
| 3. Seed Round | 01-Jan-2019 | Completed | Generating Revenue | |||
| 2. Seed Round | 01-Jan-2018 | $500K | $500K | Completed | Generating Revenue | |
| 1. Seed Round | 01-Feb-2011 | Completed | Generating Revenue |
Soluventis Nanotherapeutics Patents
Soluventis Nanotherapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| DE-202024103258-U1 | Anti-glare protection | Active | 17-Jun-2024 | ||
| DE-102020133903-A1 | Sensor device and method for detecting the presence of media using a sensor device | Pending | 17-Dec-2020 | ||
| WO-2022127996-A1 | Sensor device and method for detecting the presence of media using a sensor device | Inactive | 17-Dec-2020 | ||
| EP-3052625-A1 | Notch 1 specific sirna molecule | Active | 30-Sep-2013 | ||
| JP-2019196384-A | Notch 1 specific sirna molecule | Active | 30-Sep-2013 | C12N15/1138 |
Soluventis Nanotherapeutics Signals
Soluventis Nanotherapeutics Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Global Source Ventures | Venture Capital | Minority |
Soluventis Nanotherapeutics FAQs
-
When was Soluventis Nanotherapeutics founded?
Soluventis Nanotherapeutics was founded in 2009.
-
Where is Soluventis Nanotherapeutics headquartered?
Soluventis Nanotherapeutics is headquartered in Bochum, Germany.
-
What is the size of Soluventis Nanotherapeutics?
Soluventis Nanotherapeutics has 8 total employees.
-
What industry is Soluventis Nanotherapeutics in?
Soluventis Nanotherapeutics’s primary industry is Drug Discovery.
-
Is Soluventis Nanotherapeutics a private or public company?
Soluventis Nanotherapeutics is a Private company.
-
What is Soluventis Nanotherapeutics’s current revenue?
The current revenue for Soluventis Nanotherapeutics is .
-
How much funding has Soluventis Nanotherapeutics raised over time?
Soluventis Nanotherapeutics has raised $900K.
-
Who are Soluventis Nanotherapeutics’s investors?
Global Source Ventures has invested in Soluventis Nanotherapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process